Clinical Trial

Validation of the Artificial Intelligence Subsystem of the DDART Medical Device for the Automated Detection of Lesions Compatible With Diabetic Retinopathy in a Random Sample of Retinal Fundus Photographs

Recruiting
View on ClinicalTrials.gov →
Summary
To validate the artificial intelligence subsystem of the DDART medical device for the automated detection of lesions compatible with diabetic retinopathy in a random sample of retinal fundus photographs. Secondary Objectives To determine the sensitivity and specificity of the artificial intelligence subsystem for the detection of diabetic retinopathy. To estimate the overall diagnostic accuracy and the area under the receiver operating characteristic (ROC) curve (AUC). To compare the performance of the algorithm with that of experienced ophthalmologists. To evaluate the ability of the model to distinguish between different stages of disease severity
Trial Details
NCT Number NCT07758582
Lead Sponsor Democritus University of Thrace
Conditions Diabetic Retinopathy
Enrollment 2,000 participants
Start Date 2026-05-21
Primary Completion 2027-04-19 (estimated)
Study Completion 2027-04-19 (estimated)
Updated on ClinicalTrials.gov 2026-08-11